|
Drug Therapy, Other
Citations 151-160 of 172 total displayed.
|
Past content
(since Feb 1998):
|
- Correspondence
Effects of Intravitreous Injection of Preserved and Nonpreserved Triamcinolone in Rabbit Retina
- Petros E. Carvounis; Muhammad Abd El Barr; Thomas A. Albini; Eric R. Holz
Arch Ophthalmol 2006; 124: 1666.
[Extract]
[Full text]
[PDF]
- Socioeconomics and Health Services
Effect of Medical Therapy on Glaucoma Filtration Surgery Rates in Ontario
- Rony Rachmiel; Graham E. Trope; Mary L. Chipman; Pieter Gouws; Yvonne M. Buys
Arch Ophthalmol 2006; 124: 1472-1477.
[Abstract]
[Full text]
[PDF]
- Clinical Trials
Twice-Daily 0.2% Brimonidine–0.5% Timolol Fixed-Combination Therapy vs Monotherapy With Timolol or Brimonidine in Patients With Glaucoma or Ocular Hypertension: A 12-Month Randomized Trial
- Mark B. Sherwood; E. Randy Craven; Connie Chou; Harvey B. DuBiner; Amy L. Batoosingh; Rhett M. Schiffman; Scott M. Whitcup; for the Combigan Study Groups I and II
Arch Ophthalmol 2006; 124: 1230-1238.
[Abstract]
[Full text]
[PDF]
- Clinicopathologic Reports, Case Reports, and Small Case Series
Octreotide as a Treatment for Uveitic Cystoid Macular Edema
- Chrysanthi Kafkala; John Y. Choi; Pitipol Choopong; C. Stephen Foster
Arch Ophthalmol 2006; 124: 1353-1355.
[Extract]
[Full text]
[PDF]
- Photo Essays
Vanishing Disc Neovascularization Following Intravitreal Bevacizumab (Avastin) Injection
- Steven M. Friedlander; Robert M. Welch
Arch Ophthalmol 2006; 124: 1365.
[Extract]
[Full text]
[PDF]
- Socioeconomics and Health Services
Medicare Prescription Drug Cards: Effectiveness for Patients With Glaucoma
- Ankit A. Mahadevia; Shantanu Nundy; Kevin D. Frick; Henry D. Jampel
Arch Ophthalmol 2006; 124: 1175-1179.
[Abstract]
[Full text]
[PDF]
- Correspondence
Infliximab in Uveitis Treatment—Reply
- Eric B. Suhler; Justine R. Smith; Michael S. Wertheim; Andreas K. Lauer; Daryl E. Kurz; Terri D. Pickard; James T. Rosenbaum
Arch Ophthalmol 2006; 124: 1211-a-1212-a.
[Extract]
[Full text]
[PDF]
- Correspondence
Infliximab in Uveitis Treatment
- Nathan Rudometkin; Naresh Mandava; Kevin Deane; Jeffrey L. Olson
Arch Ophthalmol 2006; 124: 1211.
[Extract]
[Full text]
[PDF]
- Laboratory Sciences
Efficacy of Low-Release-Rate Fluocinolone Acetonide Intravitreal Implants to Treat Experimental Uveitis
- Prithvi Mruthyunjaya; Dara Khalatbari; Ping Yang; Sandra Stinnett; Ryotaro Tano; Paul Ashton; Hong Guo; Marty Nazzaro; Glenn J. Jaffe
Arch Ophthalmol 2006; 124: 1012-1018.
[Abstract]
[Full text]
[PDF]
- Controversies
Using a Drug Before the Risks and Benefits Are Known From a Phase 3 Clinical Trial: Thoughts on Compassion
- Joan W. Miller
Arch Ophthalmol 2006; 124: 1029-1031.
[Extract]
[Full text]
[PDF]
|
|
